Publication | Closed Access

FDA and NIST collaboration on standards development activities supporting innovation and translation of regenerative medicine products

Regenerative MedicinePreclinical TherapeuticsTranslational MedicineEngineeringBioequivalenceRegenerative EngineeringNist CollaborationBiotechnologyTranslational ResearchStandards Development ActivitiesRegenerative Medicine ProductsBiomedical EngineeringInnovative TreatmentDrug DevelopmentMedicineTechnology Transfer